Why the study?
Does mildly elevated fasting plasma glucose correlate with left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension?
Population
193 nondiabetic patients with treated essential hypertension. Excluded: secondary hypertension, ischemic…
Comparison
Fasting plasma glucose ≥100 mg/dl and <126 mg/dl vs Fasting plasma glucose (FPG) <100 mg/dl
Design
Cross-sectional, Echocardiographic parameters were measured by two experienced…
Key result
Fasting plasma glucose ≥100 mg/dl was associated with a significantly higher A/E ratio (1.29 vs 1.11, p=0.001) compared to <100 mg/dl in nondiabetic patients with treated essential hypertension, indicating impaired left ventricular diastolic function.
Authors
Loading...
Hypothesis-generating for mild hyperglycemia as diastolic dysfunction marker in treated hypertension; prospective studies needed before any practice implications.
Cross-Sectional (n=193)
Does mildly elevated fasting plasma glucose correlate with left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension?
Absolute Event Rate: 1.29% vs 1.11%
p-value: p=0.001
Mild elevations in fasting plasma glucose are independently associated with left ventricular diastolic dysfunction in nondiabetic hypertensive patients, independent of left ventricular hypertrophy.
Miyazato et al. (2002) conducted a cross-sectional in Treated essential hypertension (n=193). Fasting plasma glucose ≥ 100 mg/dl vs. Fasting plasma glucose < 100 mg/dl was evaluated on A/E ratio (peak velocity ratio of atrial filling to early diastolic filling) (p=0.001). Fasting plasma glucose ≥100 mg/dl was associated with a significantly higher A/E ratio (1.29 vs 1.11, p=0.001) compared to <100 mg/dl in nondiabetic patients with treated essential hypertension, indicating impaired left ventricular diastolic function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: